CHARACTERIZATION OF PLATELET-DERIVED GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR RECEPTOR EXPRESSION IN ASBESTOS-INDUCED RAT MESOTHELIOMA

被引:0
|
作者
WALKER, C
BERMUDEZ, E
STEWART, W
BONNER, J
MOLLOY, CJ
EVERITT, J
机构
[1] NIEHS,RES TRIANGLE PK,NC 27709
[2] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ 08543
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although altered expression of platelet-derived growth factor (PDGF) is a hallmark of human mesothelioma, expression of PDGF receptors has not been characterized in this cell type. In addition, the expression of this growth factor and its cognate receptor in rodent mesothelioma has not been investigated. In this study, examination of transformed mesothelial cells derived from asbestos-induced rat mesotheliomas revealed that these cells expressed high affinity PDGF receptors (K(d) = 0.5 nM) and receptor number was 1.6 x 10(5)/cell. Western analysis using antibodies specific for either the alpha-type or beta-type PDGF receptor and Northern analysis using probes specific for alpha- and beta-type receptor RNA transcripts indicated that these cells expressed beta-type PDGF receptors but that alpha-type receptors could not be detected. However, when the mesothelioma-derived cells were examined for the expression of PDGF, no expression of this growth factor could be detected. The transformed cells expressed no detectable A- or B-chain PDGF RNA transcripts; and using a competitive enzyme immunoassay specific for isoforms containing the B chain of PDGF and a sandwich enzyme-linked immunosorbent assay specific for A-chain-containing isoforms, neither AA, nor AB, nor BB isoforms of this growth factor could be detected in medium conditioned by these cells. The absence of alterations in PDGF expression in rat mesothelioma, in contrast to the data for the human disease, suggests that the production of this growth factor by transformed mesothelial cells may be species specific.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 50 条
  • [41] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    HELDIN, CH
    JOHNSSON, A
    EK, B
    WENNERGREN, S
    RONNSTRAND, L
    HAMMACHER, A
    FAULDERS, B
    WASTESON, A
    WESTERMARK, B
    METHODS IN ENZYMOLOGY, 1987, 147 : 3 - 13
  • [42] PLATELETS, PLATELET-DERIVED GROWTH-FACTOR AND ARTERIOSCLEROSIS
    BAUMGARTNER, HR
    HOSANG, M
    EXPERIENTIA, 1988, 44 (02): : 109 - 112
  • [43] PLATELET-DERIVED GROWTH-FACTOR AND MALIGNANT TRANSFORMATION
    ANTONIADES, HN
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (18) : 2823 - 2828
  • [44] PLATELET-DERIVED GROWTH-FACTOR AND MESANGIAL CELLS
    ABBOUD, HE
    KIDNEY INTERNATIONAL, 1992, 41 (03) : 581 - 583
  • [45] THE MOLECULAR ACTION OF PLATELET-DERIVED GROWTH-FACTOR
    COCHRAN, BH
    ADVANCES IN CANCER RESEARCH, 1985, 45 : 183 - 216
  • [46] STRUCTURE AND FUNCTION OF PLATELET-DERIVED GROWTH-FACTOR
    WESTERMARK, B
    HELDIN, CH
    ACTA MEDICA SCANDINAVICA, 1987, : 19 - 23
  • [47] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    ANTONIADES, HN
    SCHER, CD
    STILES, CD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (04) : 1809 - 1813
  • [48] PLATELET-DERIVED GROWTH-FACTOR IN DUPUYTRENS DISEASE
    BADALAMENTE, MA
    HURST, LC
    GRANDIA, SK
    SAMPSON, SP
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1992, 17A (02): : 317 - 323
  • [49] PLATELET-DERIVED GROWTH-FACTOR AND PROLIFERATIVE GLOMERULONEPHRITIS
    GESUALDO, L
    RANIERI, E
    PANNARALE, G
    DIPAOLO, S
    SCHENA, FP
    KIDNEY INTERNATIONAL, 1993, 43 : S86 - S89
  • [50] PLATELET-DERIVED GROWTH-FACTOR IN HUMAN GLIOMA
    WESTERMARK, B
    CARLHENDRIK, H
    NISTER, M
    GLIA, 1995, 15 (03) : 257 - 263